What you get: Semaglutide or tirzepatide prescription Ongoing check-ins with your RegenCen provider Continued monitoring of progress, symptoms, and dosing Longer-term medical guidance focused on maintaining results Best for: Patients who have lost weight and want a medically supervised plan to maintain progress
The pan-melanocortin non-selectivity, considered a clinical drawback, is precisely a scientific advantage
Current evidence suggests GLP-1 medications work best as long-term treatment, similar to blood pressure or cholesterol medications
Cardiometabolic risk factors observed endpoints of semaglutide in the STEP program [PMID: 36691308] Laboratory literature summary: Cardiometabolic risk factors observed endpoints of semaglutide in the STEP program
Realistic and Sustainable Weight Loss Goals Setting safe and sustainable weight loss goals is essential for long-term success
GLP-1 also slows stomach emptying, promoting fullness and reducing food intake